|
|
|
Oncology market in USA and Japan
|
|
|
| Anglais,
PDF, Septembre 2004, 20 pages
|
|
|
|
|
|
| Secteur analysés : |
cancer,oncology,cancer treatment,chemotherapy,...,...
|
| Type d'analyse : |
market size and estimates,market outlook |
| Marché traités : |
usa,japan,france,united kingdom |
| |
|
|
|
|
|
|
|
|
| |
 |
|
|
| |
 |
Email: |
|
Choisissez un mot de passe: |
|
Confirmez votre mot de passe: |
|
|
|
|
|
|
| |
|
|
|
| pipeline,
aromatase inhibitor,
arthritis,
biotech,
cancer,
cancer treatment,
chemotherapy,
cns,
cox 2 inhibitors,
heart failure,
immunology,
monoclonal antibody,
oncology,
osteoporosis,
rheumatoid arthritis,
stem cell,
systemic lupus erythematosus,
|
| yasuhiro tsuji ph d department manager product strategy dept r&d activity core strategic areas and sales distribution ratio jan june 2004 vs 2003 source ims 24 0 31 7 11 3 10 4 cance r 9 renal 30 bone joint cardio vascular infectio n11 others 12 cancer cardiovascular infection inner ring outer furtulon xeloda neutrogin kytril rituxan herceptin tamiflu pegasys rocephin cefotax sigmart rythmodan preran alfarol rocaltrol suvenyl evista epogin oxarol renagel rohypnol amoban ulcerlmin euglucon etc y 17 87 80 27 04 47 38 19 35 18 japan s biopharmaceutical market in chugai shares products erythropoietin 66 g csf 40 antibodies 69 415 5 billion us 55 28 growth hormone 14 insulin 8 interferons 1 blood clotting factors 2 |
|
|
| >> Marché Logiciel en France >> |
DPLSEN |
|
|
|
|
|
